protein" kinases. Aberrant functioning of transmembrane signaling mechanisms is believed to promote uncontrolled proliferation of tumor cells. Therefore, exogenous addition of GSL derivatives may correct uncontrolled growth of, and possibly induce differentiation of tumor cells. Trials of DMS and N, N, Ntrimethylsphingosine (TMS) for this purpose have been successful. Some other examples will be discussed below.
Basic structure and bifunctional role of GSLs GSLs are ubiquitous membrane components of essentially all eukaryotic cells, and are abundant in plasma membranes. Although over 150 molecular species have been identified, they can be classified into four major groups based on core structure of carbohydrate chain, : (i) ganglio-series (Gal/31 -* 3Ga1NAc/31 -* 3Galf l -* 4Glc/31-1Cer) ; (ii) globo-series (Ga1NAcf 1-> 3Galal -~ 4Gal/31 4Glcf 1-*1Cer) ; (iii) lacto-series type 1 chain (Gall 1-*3G1cNAcf 1-3Galf 1-~ 4Glc/31-*1Cer) ; and (iv) lacto-series type 2 chain (Gal/31-4G1cNAcf 1-3Ga1/31 -4Glcf1--->1Cer). Of these four groups, (i) and (ii) are believed to occur only as GSLs, whereas (iii) and (iv) occur not only as GSLs but also as peripheral regions of glycoprotein CHO chains. Upper panel : distribution patterns of GSLs revealed by electron microscopy with freeze fracture technique using ferritin-labeled monovalent MAbs. Left : clustering of globoside on human erythrocytes. Right : clustering of Forssman antigen-containing GSLs. E, external surface ; F, fractured surface (Tillack et a1.1983 ; Rock et al. 1990 ). Lower panel : conceptual model of GSL clustering to form membrane "patches." GP, glycoprotein.
According to minimum energy conformational models based on hard sphere exoanomeric (HSEA) calculations, the axis of the CHO chain in GSLs is oriented perpendicular to the axis of the lipid moiety (ceramide) which is inserted in the lipid bilayer. The upper surface of the 0110 chain in GSLs, which in most cases constitutes the hydrophobic domain and is surrounded by a hydrophilic area, is exposed at the cell surface (Hakomori 1986 ). This surface structure is the site to which various ligands complementary to GSLs are directed.
Electron micrographic studies based on freeze-etch technique using ferritinlabeled MAbs have revealed that GSLs are present at the external surface membrane, where they form large clusters rather than being distributed homogeneously in the lipid bilayer. Sometimes GSLs show a regular arrangement suggestive of a crystalline structure (Tillack et al. 1983; Rock et al. 1990 Rock et al. , 1991 . GSL clusters at the surface membrane may provide ideal loci for interaction with various ligands including animal cell lectins (e.g., selectins), antibodies, and complementary GSLs on neighboring cells (as discussed below). A conce- (Hakomori and Kannagi 1983; Hakomori 1984 Hakomori , 1989 . Here, simply for illustration, I will show five recently-characterized TACA structures based on extended type 1 chains, hybrid molecules of type 1 and type 2 chains, and extended type 2 chains with fucosyl and sialosyl substitutions (Table 1) .
Some anti-TACA MAbs have obvious applications for suppression of tumor growth and monitoring of tumor progression, although extensive further studies are necessary before such applications become a practical clinical reality.
GSLs and TA CAs as adhesion molecules
Recently, solid evidence for GSL/GSL interactions has been provided through several experimental approaches, e.g., specific interaction of GSL liposomes with GSL-coated plastic plates, auto-or hetero-aggregation of GSLcoated particles or liposomes, and affinity chromatography of GSL oligosaccharides on GSL-containing columns (Eggens et al. 1989 ; Hakomori 1989, 1991a) . LeX interacts strongly with LeX, and weakly with Leg or nLc4. H/H, H/ Leg, and N-acetyl-GM3/Gg3Cer also showed strong interaction ( Fig. 2A, 2B ). While the physiological significance (if any) of these various interactions remains to be determined, there are indications that LeX/LeX interaction plays a key triggering role in compaction of morula, the first cell adhesion event occurring in ontogenesis of vertebrates (Eggens et al. 1989) , and that H/Ley interaction initiates implantation of the embryo in endometrium (Fenderson et al. 1991) .
In other recent studies, cell adhesion mediated by GSL-GSL interaction was shown to be greatly enhanced (in terms of rapidity and intensity) when the cells express an integrin and the relevant adhesive protein is co-coated on plates with a certain GSL. For example, B16 melanoma cells (which express GM3) are known to adhere to LacCer-coated plates via GM3/LacCer interaction (Kojima and Hakomori 1991a) . When plates were co-coated with LacCer plus fibronectin or laminin, rapidity and intensity of the adhesion were enhanced 5-to 10-fold (particularly at early stages of adhesion), suggesting the importance of cofunctioning of adhesion systems based on GSL-GSL and integrin-adhesive protein interactions. It is important to note that GSL-GSL interactions occur earlier Applications based on CHO-dependent adhesion for prevention of disease processes (anti-adhesion therapy)
Since GSLs are directly involved in crucial events of cell adhesion, i.e., GSL-GSL and GSL-selectin interactions, it seems likely that application of GSLs themselves, their oligosaccharide derivatives, or anti-GSL MAbs could inhibit the Methyl-R-lactoside (but not methyl-/3-N-acetyllactosaminide, N-acetyllactosamine, or methyl-R-galactoside) has been shown to significantly inhibit lung metastasis of B16 melanoma cells. This was true not only when methyl-fllactoside and B16 cells were intravenously co-injected, but also when they were injected by different routes (e.g., methyl-f3-lactoside intraperitoneally, B16 cells intravenously) or at different times (Oguchi et al. 1990 ; Otsuji, E., Tashiro, K., Kojima, N., Hakomori, S. unpubl.) (Fig 4) . This inhibitory effect was not due to blocking of galactose-or lactose-binding lectins claimed to be present on B16 cells (Raz and Lotan 1987) , since MAbs against these lectins did not stain the B16 cells used in the experiments, nor block adhesion of B16 cells to ECs. The phenomenon seems to depend on GM3-LacCer interaction, i.e., GM3 highly expressed on B16 cells adheres to LacCer expressed on ECs. This adhesion is inhibited in the presence of methyl-f3-lactoside, LacCer, GM3, or sialidase (Kojima, N., Tashiro, K., Sadahira, Y., Hakomori, S. unpubl.). Similar approaches using sialosyl-Lex or sialosyl-Lea oligosaccharides and their derivatives for inhibition of tumor cell metastasis in humans are possible, since these CHO sequences are recognized by selectins and are therefore capable of blocking selectin binding to tumor cells.
Regulation of cell proliferation and transmembrane signaling by GSLs and their derivatives
Growth factor receptor-associated kinases, PKC, and the 0-protein family constitute the three major transmembrane signaling mechanisms which function in the majority of eukaryotic cells. The former two mechanisms are known to be modulated by gangliosides or their catabolites, particularly GM3, lyso-GM3, de-N-acetyl-GM3, SPN, and DMS (Brewer et al. 1984 (Brewer et al. , 1986 Hanai et al. 1988; Igarashi et al. 1989 Igarashi et al. , 1990 ). Insulin receptor kinase, which is regarded as an important regulator of cell growth, was specifically inhibited by sialosylparagloboside (Nojiri et al. 1991) . The effects of various GSLS and phospholipids on transmembrane signaling mechanisms are summarized in Fig. 5 .
Application of GSL and sphingolipid derivatives for control of tumor cell growth ("anti-signaling" therapy) Based on the well-documented effects of various GSL and sphingolipid derivatives on key molecules involved in transmembrane signaling and cell growth regulation, we have tested some relatively simple compounds such as DMS and TMS for possible inhibitory effects on tumor growth and metastasis. Aberrant expression of PKC is a common feature of various tumor types, and PKC and receptor-associated kinases are assumed to play essential roles in tumor progres- sion. In our recent studies, DMS and TMS were found to exert much stronger inhibitory effects (compared to previously tested reagents such as SPN, dibutyrylcAMP, and 8-chloro-CAMP) on in vitro and in vivo growth of a variety of human cancer cell lines. TMS was also found to be a strong inhibitor of tumor cellinduced platelet aggregation and B16 melanoma cell lung metastasis (Fig. 6) .
Results of these studies suggest that these compounds or their analogues, by blocking transmembrane signaling, could be useful inhibitors of tumor growth and metastasis. This "anti-signaling" approach is in obvious contrast to currently used approaches aimed at blocking of protein or nucleic acid synthesis, which involve reagents that are generally toxic and/or non-specific. and TMS were i.v. injected consecutively. One group (n = 7) was injected with 0.2 mg TMS ; another group (n = 7) was injected with 0.5 mg TMS. Right panel, effect of TMS and SPN on spontaneous metastasis. BL6 tumors were grown subcutaneously in the footpad and TMS was injected at 0.1 mg (n = 6) or 0.25 mg (n = 6). Subsequently the primary tumor was resected, and later lung colonies were counted.
